Application Note: A Label-Free, Multi-Omic Study to Qualitatively and Quantitatively Characterize the Effects of a Glucosylceramide Inhibitor on Obesity
4 November 2014

This study shows a label-free multi-omics approach to collecting qualitative and quantitative information in a single experiment, to help characterize and investigate the effects of a glucosylceramide inhibitor for treatment of obesity.